HSBC Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-5,094
Closed -$239K – 2801
2018
Q4
$239K Hold
5,094
– – ﹤0.01% 2401
2018
Q3
$285K Hold
5,094
– – ﹤0.01% 2260
2018
Q2
$257K Hold
5,094
– – ﹤0.01% 2347
2018
Q1
$251K Hold
5,094
– – ﹤0.01% 2286
2017
Q4
$262K Hold
5,094
– – ﹤0.01% 1778
2017
Q3
$265K Hold
5,094
– – ﹤0.01% 2004
2017
Q2
$263K Hold
5,094
– – ﹤0.01% 1942
2017
Q1
$256K Sell
5,094
-5,091
-50% -$252K ﹤0.01% 1884
2016
Q4
$480K Hold
10,185
– – ﹤0.01% 1875
2016
Q3
$507K Hold
10,185
– – ﹤0.01% 1564
2016
Q2
$490K Hold
10,185
– – ﹤0.01% 1580
2016
Q1
$465K Hold
10,185
– – ﹤0.01% 1574
2015
Q4
$549K Hold
10,185
– – ﹤0.01% 1650
2015
Q3
$503K Hold
10,185
– – ﹤0.01% 1400
2015
Q2
$594K Hold
10,185
– – ﹤0.01% 1365
2015
Q1
$585K Hold
10,185
– – ﹤0.01% 1507
2014
Q4
$514K Hold
10,185
– – ﹤0.01% 1479
2014
Q3
$476K Hold
10,185
– – ﹤0.01% 1486
2014
Q2
$459K Sell
10,185
-9,300
-48% -$400K ﹤0.01% 1482
2014
Q1
$823K Hold
19,485
– – ﹤0.01% 1280
2013
Q4
$765K Hold
19,485
– – ﹤0.01% 1334
2013
Q3
$692K Hold
19,485
– – ﹤0.01% 1305
2013
Q2
$651K Buy
+19,485
New +$647K ﹤0.01% 1164

Other funds holding IHE

HSBC Holdings's IHE Position: Q1 2019 in Review

HSBC Holdings sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2019, closing a stake of 5,094 shares — an estimated $239K sold.

HSBC Holdings first reported a position in IHE in Q2 2013 and held it in 23 quarters. The position peaked at $823K in Q1 2014. 91 funds tracked by Wall St. Rank hold IHE as of Q1 2019.

  • HSBC Holdings reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
  • HSBC Holdings sold 5,094 iShares US Pharmaceuticals ETF shares in Q1 2019, an estimated $239K.
  • HSBC Holdings first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 23 quarters.
  • HSBC Holdings's iShares US Pharmaceuticals ETF position peaked at $823K in Q1 2014.
  • 91 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2019.

Based on HSBC Holdings's 13F filing for Q1 2019, filed 15 May 2019.